Beam ipo date
WebBEAM IPO Price: (view offering) BEAM IPO Date: February 6, 2024 Industry: Biotechnology View info for the Beam Therapeutics IPO at ClickIPO. Toggle navigation … WebFeb 6, 2024 · Founded in 2024 by gene editing pioneers, Beam Therapeutics raised gross proceeds of $180 million through its IPO of 10,588,236 shares at $17 a share. Beam priced its shares at the high end of its ...
Beam ipo date
Did you know?
WebJan 27, 2024 · Beam Therapeutics has filed to raise $100 million in a U.S. IPO. The firm is advancing genetic treatments for various diseases. BEAM is still in pre-clinical stage and … WebApr 11, 2024 · CAMBRIDGE, Mass., March 21, 2024 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision …
WebApr 13, 2024 · 10 Wall Street research analysts have issued twelve-month target prices for Beam Therapeutics' stock. Their BEAM share price forecasts range from $37.00 to $105.00. On average, they expect the company's stock price to reach $72.40 in the next twelve months. This suggests a possible upside of 143.6% from the stock's current price. WebFeb 6, 2024 · The offering is expected to close on February 10, 2024, subject to the satisfaction of customary closing conditions. J.P. Morgan, Jefferies and Barclays are …
WebOct 1, 2024 · CAMBRIDGE, Mass., Sept. 30, 2024 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced...
WebTo date, we have developed working prototypes for both our telehealth product and our ER product. The ER Product is currently undergoing additional engineering work that we …
WebDec 5, 2024 · Beam Therapeutics (NASDAQ:BEAM) is a preclinical stage biopharma with a $3.3B market cap and a recent IPO whose chart looks like this:Source. We have been observing, in recent years, these sorts ... get the point sickanWebMar 27, 2024 · BlackRock Increases Position in Beam Therapeutics (BEAM) Fintel • Feb 2, 2024 Cantor Fitzgerald Initiates Coverage of Beam Therapeutics (BEAM) with … get the point ルールWebBeam Therapeutics closed its last funding round on Jan 19, 2024 from a Post-IPO Equity round. Who are Beam Therapeutics 's competitors? Alternatives and possible competitors to Beam Therapeutics may include QurAlis , Chroma Medicine , and Seamless Therapeutics. Unlock even more features with Crunchbase Pro Start Your Free Trial getthepomWebFeb 11, 2024 · CAMBRIDGE, Mass. -- (BUSINESS WIRE)--Feb. 11, 2024-- Beam Therapeutics Inc. (Nasdaq:BEAM), a biotechnology company developing precision … christoph caspar viadonauWebNov 26, 2024 · The cargo drone company will be looking to raise €3M which is the maximum amount available on the BEAM market. To raise the target sum, Dronamics will offer individual investors 5 334 081 preference, dematerialized, Class B shares with €0.5 nominal value of each share. The news is followed by the announcement that “The Black Swan”, … get the point my morning jacket lyricsWebApr 6, 2024 · Beam Global has a market cap or net worth of $131.89 million. The enterprise value is $131.85 million. Important Dates The next earnings date is Tuesday, May 23, 2024, after market close. Share Statistics Beam Global has 10.84 million shares outstanding. The number of shares has increased by 11.56% in one year. Valuation Ratios christoph caspar carna galloWebOct 4, 2024 · Beam Therapeutics (NASDAQ:BEAM) has filed to raise gross proceeds of up to $100 million from a U.S. IPO, according to an S-1 registration statement. christoph carl korbach